A Study of JNJ-64140284 Solid Dose Formulations in Healthy Male Participants

NCT04033458 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

1

Enrollment

INDUSTRY

Sponsor class

Stopped stopped because of a business decision

Conditions

Healthy

Interventions

DRUG: JNJ-64140284

Sponsor

Janssen Research & Development, LLC